STAT3 mutations in the hyper-IgE syndrome

New England Journal of Medicine

Volumn 357, Issue 16, 2007, Pages 1608-1619

  Holland, Steven M ^a   DeLeo, Frank R ^b   Elloumi, Houda Z ^a   Hsu, Amy P ^a   Uzel, Gulbu ^a   Brodsky, Nina ^a   Freeman, Alexandra F ^a   Demidowich, Andrew ^a   Davis, Joie ^c   Turner, Maria L ^d   Anderson, Victoria L ^a   Darnell, Dirk N ^a   Welch, Pamela A ^a   Kuhns, Douglas B ^f   Frucht, David M ^g   Malech, Harry L ^a   Gallin, John I ^a   Kobayashi, Scott D ^b   Whitney, Adeline R ^b   Voyich, Jovanka M ^b   Musser, James M ^b   Woellner, Cristina ^h   Schäffer, Alejandro A ^e   Puck, Jennifer M ⁱ   Grimbacher, Bodo ^h   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f SAIC FREDERICK INC   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN SH2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CELL SECRETION; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HYPERIMMUNOGLOBULINEMIA E; IMMUNE DEFICIENCY; INNATE IMMUNITY; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; MISSENSE MUTATION; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; RECURRENT INFECTION; STAT3 GENE;

EID: 35348960378     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa073687     Document Type: Article

References (39)

1. Davis SD, Schaller J, Wedgwood RJ. Job's syndrome: recurrent, "cold," staphylococcal abscesses. Lancet 1966;1:1013-5.
2. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972;49:59-70.
3. Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999;340:692-702.
4. Buckley RH. The hyper-IgE syndrome. Clin Rev Allergy Immunol 2001;20:139-54.
5. Ling JC, Freeman AF, Gharib AM, et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 2007;122:255-8.
6. Freeman AF, Collura-Burke CJ, Patronas NJ, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007;119:e1121-e1125.
7. Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007;119:1234-40.
8. Del Prete G, Tiri A, Maggi E, et al. Defective in vitro production of γ-interferon and tumor necrosis factor-α by circulating T cells from patients with the hyperimmunoglobulin E syndrome. J Clin Invest 1989;84:1830-5.
9. Grimbacher B, Schäffer AA, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999;65:735-44.
10. Chehimi J, Elder M, Greene J, et al. Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin Immunol 2001;100:49-56.
11. Tanaka T, Takada H, Nomura A, Ohga S, Shibata R, Hara T. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol 2005;140:524-31.
12. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci U S A 2002;99:6901-6.
13. Kobayashi SD, Voyich JM, Braughton KR, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 2004;172:636-43.
14. Holland SM, Dorman SE, Kwon A, et al. Abnormal regulation of interferon-γ, interleukin-12, and tumor necrosis factor-α in human interferon-γ receptor 1 deficiency. J Infect Dis 1998;178:1095-104.
15. Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999;90:425-30.
16. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect function. Genome Res 2002;12:436-46.
17. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894-900.
18. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007;178:2623-9.
19. Maritano D, Sugrue ML, Tininini S, et al. The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol 2004;5:401-9.
20. Welte T, Zhang SSM, Wang T, et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A 2003;100:1879-84.
21. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
22. Sakamoto E, Hato F, Kato T, et al. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2. J Leukoc Biol 2005;78:301-9.
23. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058-62.
24. Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997;94:3801-4.
25. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745-55.
26. Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004;144:93-9.
27. Hokuto I, Ikegami M, Yoshida M, et al. Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 2004;113:28-37
28. Panopoulos AD, Zhang L, Snow JW, et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 2006;108:3682-90.
29. Zhang Z, Welte T, Troiano N, Maher SE, Fu X-F, Bothwell ALM. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem Biophys Res Commun 2005;328:800-7.
30. Freeman AF, Ling J, Collins M, et al. Minimal trauma fractures and reduced bone mineral density in hyper IgE syndrome. Presented at the Pediatric Academic Societies' Annual Meeting, Toronto, May 5-8, 2007. abstract.
31. Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367-80.
32. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54.
33. Jacoby JJ, Kalinowski A, Liu M-G, et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A 2003;100:12929-34.
34. Okada S, Nakamura M, Katoh H, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006;12:829-34.
35. Wooten DK, Xie X, Bartos D, et al. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J Biol Chem 2000;275:26566-75.
36. 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. J Biol Chem 2002;277:19001-7.
37. Wang L, Arcasoy MO, Watowich SS, Forget BG. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells. Exp Hematol 2005;33:308-17.
38. Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007;282:9358-63.
39. Ozaki K, Spolski R, Feng CG, et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002;298:1630-4.